AARTIPHARM
Invest with MTF
Invest Now
Invest in Aarti Pharmalabs with 2.86X leverage
Aarti Pharmalabs live price: ₹700.15. It opened at ₹702 vs previous close ₹699; intraday high/low: ₹708/₹689. The 50 & 200 DMA stand at ₹736.47/₹768.32.
Aarti Pharmalabs Performance
- Low
- ₹689
- High
- ₹708
- 52 Week Low
- ₹574
- 52 Week High
- ₹971
- Open Price₹702
- Previous Close₹699
- Volume96,779
- 50 DMA₹736.47
- 100 DMA₹757.78
- 200 DMA₹768.32
Investment Returns
- Over 1 Month -9.87%
- Over 3 Month -2.97%
- Over 6 Month -20.68%
- Over 1 Year -5.26%
Smart Investing Starts Here Start SIP with Aarti Pharmalabs for Steady Growth!
Aarti Pharmalabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 29.7
- PEG Ratio
- -2.1
- Market Cap Cr
- 6,347
- P/B Ratio
- 3
- Average True Range
- 26.38
- EPS
- 23.81
- Dividend Yield
- 0.6
- MACD Signal
- -14.03
- RSI
- 43.62
- MFI
- 49.27
Aarti Pharmalabs Financials
Aarti Pharmalabs Technicals
EMA & SMA
Current Price
₹700.15
+
1.3
(0.19%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹716.75
- 50 Day
- ₹736.47
- 100 Day
- ₹757.78
- 200 Day
- ₹768.32
Resistance and Support
698.85
- R3 728.60
- R2 718.25
- R1 709.20
- S1 689.80
- S2 679.45
- S3 670.40
Aarti Pharmalabs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-09 | Quarterly Results & Interim Dividend | |
| 2025-11-09 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-10 | Audited Results & Final Dividend | |
| 2025-02-05 | Quarterly Results, Dividend & Others | To consider other business matters. per share(40%)Interim Dividend |
Aarti Pharmalabs F&O
About Aarti Pharmalabs
- NSE Symbol
- AARTIPHARM
- BSE Symbol
- 543748
- Managing Director
- Mr. Narendra J Salvi
- ISIN
- INE0LRU01027
Similar Stocks to Aarti Pharmalabs
Aarti Pharmalabs FAQs
Aarti Pharmalabs share price is ₹700 As on 09 March, 2026 | 02:54
The Market Cap of Aarti Pharmalabs is ₹6347.4 Cr As on 09 March, 2026 | 02:54
The P/E ratio of Aarti Pharmalabs is 29.7 As on 09 March, 2026 | 02:54
The PB ratio of Aarti Pharmalabs is 3 As on 09 March, 2026 | 02:54
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.